| UniProt ID | UB2E1_HUMAN | |
|---|---|---|
| UniProt AC | P51965 | |
| Protein Name | Ubiquitin-conjugating enzyme E2 E1 | |
| Gene Name | UBE2E1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 193 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. Catalyzes the covalent attachment of ISG15 to other proteins. Mediates the selective degradation of short-lived and abnormal proteins. In vitro also catalyzes 'Lys-48'-linked polyubiquitination.. | |
| Protein Sequence | MSDDDSRASTSSSSSSSSNQQTEKETNTPKKKESKVSMSKNSKLLSTSAKRIQKELADITLDPPPNCSAGPKGDNIYEWRSTILGPPGSVYEGGVFFLDITFTPEYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLVGSIATQYMTNRAEHDRMARQWTKRYAT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSDDDSRAS ------CCCCCCCCC | 50.15 | 28355574 | |
| 2 | Acetylation | ------MSDDDSRAS ------CCCCCCCCC | 50.15 | 19413330 | |
| 6 | Phosphorylation | --MSDDDSRASTSSS --CCCCCCCCCCCCC | 36.42 | 28450419 | |
| 9 | Phosphorylation | SDDDSRASTSSSSSS CCCCCCCCCCCCCCC | 27.93 | 22115753 | |
| 10 | Phosphorylation | DDDSRASTSSSSSSS CCCCCCCCCCCCCCC | 31.48 | 28450419 | |
| 11 | Phosphorylation | DDSRASTSSSSSSSS CCCCCCCCCCCCCCC | 26.23 | 28450419 | |
| 12 | Phosphorylation | DSRASTSSSSSSSSN CCCCCCCCCCCCCCC | 34.04 | 28450419 | |
| 13 | Phosphorylation | SRASTSSSSSSSSNQ CCCCCCCCCCCCCCC | 33.72 | 28450419 | |
| 14 | Phosphorylation | RASTSSSSSSSSNQQ CCCCCCCCCCCCCCC | 35.87 | 28450419 | |
| 15 | Phosphorylation | ASTSSSSSSSSNQQT CCCCCCCCCCCCCCC | 35.87 | 28450419 | |
| 16 | Phosphorylation | STSSSSSSSSNQQTE CCCCCCCCCCCCCCC | 39.47 | 28450419 | |
| 17 | Phosphorylation | TSSSSSSSSNQQTEK CCCCCCCCCCCCCCC | 34.94 | 26074081 | |
| 18 | Phosphorylation | SSSSSSSSNQQTEKE CCCCCCCCCCCCCCC | 40.37 | 23401153 | |
| 22 | Phosphorylation | SSSSNQQTEKETNTP CCCCCCCCCCCCCCC | 38.98 | 28450419 | |
| 24 | Ubiquitination | SSNQQTEKETNTPKK CCCCCCCCCCCCCCH | 73.55 | 21906983 | |
| 26 | Phosphorylation | NQQTEKETNTPKKKE CCCCCCCCCCCCHHH | 56.30 | 28450419 | |
| 28 | Phosphorylation | QTEKETNTPKKKESK CCCCCCCCCCHHHHH | 43.86 | 26055452 | |
| 43 | Acetylation | VSMSKNSKLLSTSAK CCCCHHHHHHHHHHH | 63.94 | 25953088 | |
| 43 | Sumoylation | VSMSKNSKLLSTSAK CCCCHHHHHHHHHHH | 63.94 | - | |
| 43 | Ubiquitination | VSMSKNSKLLSTSAK CCCCHHHHHHHHHHH | 63.94 | 21906983 | |
| 43 | Sumoylation | VSMSKNSKLLSTSAK CCCCHHHHHHHHHHH | 63.94 | - | |
| 46 | Phosphorylation | SKNSKLLSTSAKRIQ CHHHHHHHHHHHHHH | 30.65 | 23312004 | |
| 47 | Phosphorylation | KNSKLLSTSAKRIQK HHHHHHHHHHHHHHH | 32.45 | 23312004 | |
| 50 | Ubiquitination | KLLSTSAKRIQKELA HHHHHHHHHHHHHHH | 50.21 | - | |
| 50 | Acetylation | KLLSTSAKRIQKELA HHHHHHHHHHHHHHH | 50.21 | 25953088 | |
| 54 | Ubiquitination | TSAKRIQKELADITL HHHHHHHHHHHHCCC | 52.93 | - | |
| 55 | Acetylation | SAKRIQKELADITLD HHHHHHHHHHHCCCC | 32.58 | - | |
| 72 | Ubiquitination | PNCSAGPKGDNIYEW CCCCCCCCCCCEEEE | 77.35 | - | |
| 77 | Phosphorylation | GPKGDNIYEWRSTIL CCCCCCEEEECCCEE | 18.72 | 28152594 | |
| 136 | Acetylation | VICLDILKDNWSPAL EEEEEHHCCCCCCCH | 49.72 | 26051181 | |
| 136 | Ubiquitination | VICLDILKDNWSPAL EEEEEHHCCCCCCCH | 49.72 | 21906983 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UB2E1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UB2E1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UB2E1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-9 AND SER-12, ANDMASS SPECTROMETRY. | |
| "An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-77, AND MASSSPECTROMETRY. | |